These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31285771)

  • 1. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.
    Hong C; Wang D; Liang J; Guo Y; Zhu Y; Xia J; Qin J; Zhan H; Wang J
    Theranostics; 2019; 9(15):4437-4449. PubMed ID: 31285771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells.
    Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J
    J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy.
    Zhu Y; Liang J; Gao C; Wang A; Xia J; Hong C; Zhong Z; Zuo Z; Kim J; Ren H; Li S; Wang Q; Zhang F; Wang J
    J Control Release; 2021 Feb; 330():641-657. PubMed ID: 33359582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
    Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J
    Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer].
    Liu H; Liu Y; Li N; Zhang GQ; Wang M
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3472-3484. PubMed ID: 37474984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs.
    Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J
    Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel "Carrier-Free" Nanofiber Codelivery Systems with the Synergistic Antitumor Effect of Paclitaxel and Tetrandrine through the Enhancement of Mitochondrial Apoptosis.
    Li X; Yu N; Li J; Bai J; Ding D; Tang Q; Xu H
    ACS Appl Mater Interfaces; 2020 Mar; 12(9):10096-10106. PubMed ID: 32027119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity.
    Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J
    Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Antitumor Activity of Novel Redox-Responsive Paclitaxel-Encapsulated Liposomes Based on Disulfide Phosphatidylcholine.
    Du Y; Wang Z; Wang T; He W; Zhou W; Li M; Yao C; Li X
    Mol Pharm; 2020 Jan; 17(1):262-273. PubMed ID: 31747284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
    Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
    Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors.
    Gao F; Ma Z; Luo X; Wang Y; Liu X; Tang M; Chen J; Tu L; Ouyang D; Zheng J; Li C
    Mol Pharm; 2024 Jul; 21(7):3502-3512. PubMed ID: 38861472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
    Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
    Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
    Hong C; Liang J; Xia J; Zhu Y; Guo Y; Wang A; Lu C; Ren H; Chen C; Li S; Wang D; Zhan H; Wang J
    Nanomicro Lett; 2020 Jun; 12(1):129. PubMed ID: 34138128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy.
    Jin X; Yang Q; Cai N
    Int J Nanomedicine; 2018; 13():3827-3838. PubMed ID: 30013338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes.
    Guan J; Sun J; Sun F; Lou B; Zhang D; Mashayekhi V; Sadeghi N; Storm G; Mastrobattista E; He Z
    Nanoscale; 2017 Jul; 9(26):9190-9201. PubMed ID: 28650490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
    Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
    Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.